Iovance Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.64-$9.38 |
Market Cap | $968.6M |
Shares Short | 115M |
Financials
See moreRevenue (12 Mos) | $250.4M |
Revenue Growth (YoY) | 15.2% |
Gross Profit (12 Mos) | $51.8M |
Diluted EPS | -$1.19 |
News
See moreYahoo Finance • 8 days ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 23 days ago
Iovance Biotherapeutics reports mixed Q3 results; reaffirms FY25 outlook
Yahoo Finance • last month
IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders
Yahoo Finance • 2 months ago
Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire?
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 838 |
